Emerging Therapies for Diabetes and Obesity
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 15 January 2026 | Viewed by 67
Special Issue Editor
Special Issue Information
Dear Colleagues,
Diabetes and obesity are among the most pressing global health challenges of the 21st century. Their growing prevalence, along with the high burden of associated comorbidities such as cardiovascular disease, non-alcoholic fatty liver disease, and neurodegeneration, demands innovative and effective therapeutic approaches. While current pharmacological treatments provide benefits in glycemic control and weight reduction, long-term efficacy, safety, and patient adherence remain significant concerns.
This Special Issue, “Emerging Therapies for Diabetes and Obesity”, aims to highlight the latest advances in the development of novel therapeutic agents, including small molecules, biologics, phytochemicals, and metabolic modulators. Of particular interest are interventions targeting insulin resistance, adipose tissue dysfunction, beta-cell preservation, gut-brain axis regulation, and inflammation. We also welcome research focused on combination therapies, drug repurposing, and personalized medicine approaches that consider genetic, metabolic, and lifestyle factors.
Submissions may include original research articles, preclinical studies, clinical trials, reviews, and meta-analyses that offer mechanistic insights or translational relevance. Interdisciplinary contributions at the interface of pharmacology, molecular biology, endocrinology, and systems medicine are especially encouraged.
Through this Special Issue, we aim to provide a comprehensive and up-to-date overview of emerging pharmacological strategies for the prevention and treatment of diabetes and obesity, ultimately contributing to the discovery of safer, more effective, and sustainable therapeutic options for patients worldwide.
Dr. Pedro Cisternas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- insulin resistance
- adipose tissue dysfunction
- antidiabetic agents
- metabolic disease
- metabolic inflammation
- pharmacological interventions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
